🔗 Share this article

An underground market for unlicensed slimming drugs is propelled by TikTok fitness influencers and sellers on messaging platforms, based on new investigations.

Experimental Treatment Acquiring Popularity Via Social Media

The experimental drug, which is still in clinical trials, is being promoted by social media influencers for its alleged weight-reducing properties. Followers are urged to message these accounts directly for supplier links, while also receiving promotional offers.

Thriving Commerce on Social Networks

Separately, a robust market exists on messaging services, where communities with thousands of participants share comparison photos, injection guides and claims of next-day British shipping. Vendors market the drug there before redirecting buyers to other platforms for purchases.

Learning About Retatrutide

Retatrutide is an investigational injection developed by American pharmaceutical company Eli Lilly. The drug affects three gut hormones – GLP-1, GIP and glucagon. Preliminary studies indicate it could help individuals lose up to 25% of their body weight. Nicknamed the “triple G”, the drug is being hailed online as the next Ozempic.

Healthcare Professionals Voice Worries

However, doctors and pharmacists have warned that the sale of what is still an unapproved drug in the UK is a cause for concern and could result in individuals injecting substances of unknown origin.

Some experts said the demand for the experimental drug could be connected to the rising cost of licensed weight loss treatments such as Mounjaro.

Legal Status and Enforcement

Selling retatrutide on social media or messaging apps is prohibited in the UK, as it is an unapproved drug that must not be promoted or distributed for personal consumption under the Human Medicines Regulations 2012.

Several influencers try to circumvent the regulations by calling to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted drug, but promotion and supply can still breach medicines, marketing, and customer regulations, potentially leading to penalties, legal action or imprisonment.

Service Response and Material Elimination

According to TikTok, the platform has removed problematic content and prohibited associated keywords and search suggestions. The organization said it was dedicated to keeping the service secure and allocating resources in strengthening compliance measures.

Digital Marketplace Operations

Research also found groups with up to nine thousand participants selling the experimental drug using the platform's built-in search feature, which functions like a public directory. Typing “retatrutide” immediately brings up channels with numerous of members, populated with images of weight loss, glowing testimonials and detailed guides for mixing or injecting at home.

Within minutes of entering one group, a seller posted contact information, where most purchases occur. The seller provided an guidebook and promised shipping within two days. When asked whether the substance was authentic, one seller said: “You can’t be sure.” Another shared a photo of a supposed testing documentation. None inquired about body mass, medical conditions or previous experience.

Item Details and Costs

Within these communities, messages show black plastic parcels with postal service stickers, stating to include fresh supplies. One message stated: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, mixed at home with sterile water, or ready-to-use pens usually sold at 160 pounds for 20 milligrams. When questioned how long a injector should last, vendors give contradictory responses ranging from a few weeks to “depends on your body”.

Service Moderation and Security Actions

A representative for Telegram stated it regularly moderated dangerous material on its service including material that encouraged the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.

Healthcare Professional Cautions

“People are administering materials they can’t verify. Even if the science behind retatrutide is sound, these digital products may not include what they claim,” stated a pharmacy expert, the director of pharmacy at Chemist4U.

Dr Crystal Wyllie of Asda Online Doctor linked the surge in interest to current cost increases for approved weight-loss drugs such as Mounjaro. “With prices rising, patients are using online platforms. But fake injections are extremely risky. You can’t be certain what’s inside or whether the conditions they were made in was sterile,” she explained.

Her staff has already encountered patients injured by self-injection from unconfirmed sources. “We understand the disappointment, but buying from Telegram or communication platforms is gambling with your health,” stated the doctor. “These substances could be contaminated or incorrectly dosed.”

Producer Position

A representative from the pharmaceutical company said the substance was in third stage research studies and had not been reviewed or authorized by any regulatory agency globally. “Therefore at this point no one can sell [it] for personal consumption,” they said, noting that any product “misleadingly claiming itself as a Lilly investigational substance not yet approved … may expose patients to potentially significant medical dangers”.